Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Valvular Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 294 articles: HTML format

Single Articles

December 2025
1. ZUIN M, Balla C, Canovi L, Serenelli M, et al
   Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy.
   Int J Cardiol. 2025;440:133680.
   PubMed     Abstract available
   
   
   
2. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
   Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
   Int J Cardiol. 2025;440:133699.
   PubMed    
   
   
   
3. PANG X, Zhao S, Zhang F
   Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
   Int J Cardiol. 2025;440:133698.
   PubMed    
   
   
   November 2025
4. SHATANOF R, Ghay S, Fernandez R, Elajami TK, et al
   Cardiac morphologic and functional characteristics in patients with left ventricular excessive Trabeculation versus apical hypertrophic cardiomyopathy.
   Int J Cardiol. 2025;439:133650.
   PubMed     Abstract available
   
   
   October 2025
5. SCHOONVELDE SAC, Nollet EE, Zwetsloot PP, Knackstedt C, et al
   Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.
   Int J Cardiol. 2025;437:133444.
   PubMed     Abstract available
   
   
   September 2025
6. KIRK BH, Palm P, Norgaard MW, Borregaard B, et al
   Prevention of readmission by intensified follow-up after transcatheter aortic valve implantation: Feasibility results of the PREMISS randomised controlled trial.
   Int J Cardiol. 2025 Sep 14:133894. doi: 10.1016/j.ijcard.2025.133894.
   PubMed     Abstract available
   
   
   
7. ZAHID MH, Saleem M, Murtaza A
   Letter to the editor: Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
   Int J Cardiol. 2025 Sep 6:133859. doi: 10.1016/j.ijcard.2025.133859.
   PubMed    
   
   
   
8. LUNZE FI, Dusenbery SM, Gauvreau K, Lee JM, et al
   Mid-term ventricular function in patients with tetralogy of Fallot after transcatheter pulmonary valve replacement: Relationship to baseline right ventricular loading conditions.
   Int J Cardiol. 2025;434:133305.
   PubMed     Abstract available
   
   
   August 2025
9. DUAN YN
   Letter to the editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
   Int J Cardiol. 2025 Aug 26:133829. doi: 10.1016/j.ijcard.2025.133829.
   PubMed    
   
   
   
10. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to Letter to the Editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Reinterpreting patient characteristics and institutional effects.
    Int J Cardiol. 2025 Aug 26:133830. doi: 10.1016/j.ijcard.2025.133830.
    PubMed    
    
    
    
11. MARGONATO D, Morosato M, Ingallina G, Wang C, et al
    Natural history outcome of moderate tricuspid regurgitation with preserved left-ventricular ejection fraction.
    Int J Cardiol. 2025;442:133826.
    PubMed     Abstract available
    
    
    
12. DONAL E, Rasmeehirun P, Petersen Saadi M
    From bottle to decanter: Revisiting eRVSP accuracy in the five-grade tricuspid regurgitation era.
    Int J Cardiol. 2025 Aug 20:133805. doi: 10.1016/j.ijcard.2025.133805.
    PubMed    
    
    
    
13. MELILLO F, Speziale G
    Mitral valve treatment for mitral valve regurgitation: The past, the present and the future - A challenge for the surgeon and the imager.
    Int J Cardiol. 2025 Aug 19:133784. doi: 10.1016/j.ijcard.2025.133784.
    PubMed    
    
    
    
14. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to letter to editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 19:133808. doi: 10.1016/j.ijcard.2025.133808.
    PubMed    
    
    
    
15. GITTO M, Kim WK, Buono A, Fabris T, et al
    Clinical outcomes in women and men with raphe-type bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2025;441:133792.
    PubMed     Abstract available
    
    
    
16. FENG D, Wang M, Wang J, Liu X, et al
    Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patients.
    Int J Cardiol. 2025;441:133791.
    PubMed     Abstract available
    
    
    
17. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    PubMed     Abstract available
    
    
    
18. ANNALISA P, Andrea P, Monica F, Giuseppe C, et al
    Genereux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation.
    Int J Cardiol. 2025 Aug 12:133770. doi: 10.1016/j.ijcard.2025.133770.
    PubMed     Abstract available
    
    
    
19. TARTAGLIA F, Gitto M, Villaschi A, Calamita G, et al
    Transcatheter therapies for tricuspid regurgitation: A meta-analysis of randomized trials.
    Int J Cardiol. 2025 Aug 11:133777. doi: 10.1016/j.ijcard.2025.133777.
    PubMed     Abstract available
    
    
    
20. YANG T, Wang Y, Zhu G, Liu W, et al
    TRI-PLAN: A deep learning-based automated assessment framework for right heart assessment in transcatheter tricuspid valve replacement planning.
    Int J Cardiol. 2025 Aug 6:133732. doi: 10.1016/j.ijcard.2025.133732.
    PubMed     Abstract available
    
    
    
21. YU C
    Letter to the editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 6:133723. doi: 10.1016/j.ijcard.2025.133723.
    PubMed    
    
    
    
22. MEI Z, Guo C, Yang H, Li J, et al
    Serum Alpha-1-microglobulin (A1M) as an independent predictor of calcific aortic valve stenosis and its diagnostic value.
    Int J Cardiol. 2025;440:133706.
    PubMed     Abstract available
    
    
    
23. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    PubMed     Abstract available
    
    
    
24. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    PubMed    
    
    
    
25. SHI W, Wang M, Niu G, Zhao Z, et al
    Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance.
    Int J Cardiol. 2025;432:133263.
    PubMed     Abstract available
    
    
    
26. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    PubMed    
    
    
    July 2025
27. GHAFFAR MD, Khan MA
    Refining patient selection and outcome assessment in transcatheter edge-to-edge mitral valve repair: Reflections on a Nationwide Danish study.
    Int J Cardiol. 2025;440:133679.
    PubMed    
    
    
    
28. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    PubMed    
    
    
    
29. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    PubMed     Abstract available
    
    
    
30. ROGERS LJ, Dong T, Kota R, Chan J, et al
    Reoperative mitral valve surgery in the UK: 20-year trends and early outcomes.
    Int J Cardiol. 2025 Jul 5:133602. doi: 10.1016/j.ijcard.2025.133602.
    PubMed     Abstract available
    
    
    
31. XU Z, Chen L, Dai X, Lin Z, et al
    Midterm outcomes of thoracoscopic trans-mitral myectomy for hypertrophic obstructive cardiomyopathy: A single-center, observational study.
    Int J Cardiol. 2025;430:133216.
    PubMed     Abstract available
    
    
    June 2025
32. CELEGHIN R, Pilichou K
    Mitral valve prolapse: A clinical puzzle in search of molecular solutions.
    Int J Cardiol. 2025 Jun 30:133563. doi: 10.1016/j.ijcard.2025.133563.
    PubMed    
    
    
    
33. REN CB, van den Dorpel MMP, Geleijnse M, van Mieghem NM, et al
    How accurate is intraprocedural transthoracic echocardiography in assessing aortic regurgitation after transcathether aortic valve implantation? A single center experience.
    Int J Cardiol. 2025;438:133565.
    PubMed     Abstract available
    
    
    
34. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    PubMed    
    
    
    
35. BARILI F, Pollari F, Marin-Cuartas M, Anselmi A, et al
    Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025 Jun 24:133524. doi: 10.1016/j.ijcard.2025.133524.
    PubMed     Abstract available
    
    
    
36. SCHOPS LB, Truong S, Petersen J, Alhakak A, et al
    Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025;438:133552.
    PubMed     Abstract available
    
    
    
37. SCHREURS BA, van Kimmenade RRJ, Eijsvogels TMH
    Reply by Schreurs et al. to letter regarding article: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025 Jun 20:133545. doi: 10.1016/j.ijcard.2025.133545.
    PubMed    
    
    
    
38. IMRAN A, Haider A
    Comment on "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study".
    Int J Cardiol. 2025;438:133534.
    PubMed    
    
    
    
39. AWAD DM
    Bridging the Gap: Addressing the Underuse of Transcatheter Edge-to-Edge Repair in Chinese Patients with Significant Mitral Regurgitation.
    Int J Cardiol. 2025;438:133519.
    PubMed    
    
    
    
40. VESELKA J, Hansvenclova E, Tesarkova KH, Januska J, et al
    Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;429:133145.
    PubMed     Abstract available
    
    
    
41. LORENZATTI A
    Cholesterol and Valvular heart disease: Is Lipoprotein(a) the sole culprit?
    Int J Cardiol. 2025;437:133510.
    PubMed    
    
    
    
42. TREMAMUNNO G, De Santis D, Santangeli C, Bona GG, et al
    Comparative analysis of pre-transcatheter aortic valve implantation CTA protocols: Optimizing radiation dose and contrast volume.
    Int J Cardiol. 2025;437:133514.
    PubMed     Abstract available
    
    
    
43. JARRAR Y, Alomari L, Otabor E, Lam J, et al
    A safer bet for MitraClip: Choosing between single antiplatelet therapy and dual antiplatelet therapy.
    Int J Cardiol. 2025;437:133476.
    PubMed     Abstract available
    
    
    May 2025
44. LORETZ L, Kim WK, de Backer O, Brunner S, et al
    PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement - A multicenter retrospective registry analysis.
    Int J Cardiol. 2025;436:133428.
    PubMed     Abstract available
    
    
    
45. TRUONG S, Fosbol E, Ostergaard L
    Reply to "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective".
    Int J Cardiol. 2025 May 27:133431. doi: 10.1016/j.ijcard.2025.133431.
    PubMed    
    
    
    
46. NONAKA H, Asami M, Horiuchi Y, Tanaka J, et al
    Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry.
    Int J Cardiol. 2025 May 27:133427. doi: 10.1016/j.ijcard.2025.133427.
    PubMed     Abstract available
    
    
    
47. EBRAHIMI S
    Early aortic valve replacement in asymptomatic severe aortic stenosis: A turning point in management.
    Int J Cardiol. 2025;435:133411.
    PubMed    
    
    
    
48. BLACKMAN DJ, Aktaa S, Pickles D, Abdel-Wahab M, et al
    REdo transcatheter aortic VALVE implantation for the management of transcatheter aortic valve failure: Design and rationale of the REVALVE study.
    Int J Cardiol. 2025 May 18:133400. doi: 10.1016/j.ijcard.2025.133400.
    PubMed     Abstract available
    
    
    
49. HASSAN SAU, Huda NU, Maheen M
    Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025;435:133392.
    PubMed    
    
    
    
50. JABRI A, Suri RM, Villablanca P
    Redo or Redon't? Mitral valve reoperation vs. first-time surgery outcomes: A nationwide study.
    Int J Cardiol. 2025;434:133353.
    PubMed    
    
    
    
51. FATH AR, Aglan A, Maron MS, Phillips JS, et al
    Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;426:133082.
    PubMed     Abstract available
    
    
    April 2025
52. CHEN B, Wang C, Li W
    Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation.
    Int J Cardiol. 2025 Apr 29:133325. doi: 10.1016/j.ijcard.2025.133325.
    PubMed     Abstract available
    
    
    
53. SCHREURS BA, van der Sluijs KM, Hopman MTE, Bakker EA, et al
    Physical activity characteristics in adults with bicuspid aortic valve versus age- and sex-matched controls.
    Int J Cardiol. 2025 Apr 29:133330. doi: 10.1016/j.ijcard.2025.133330.
    PubMed     Abstract available
    
    
    
54. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    Reply to: Correction to external evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2025;433:133310.
    PubMed    
    
    
    
55. WEI P, Zhao G, Dong J, Feng S, et al
    Anatomical suitability and clinical outcomes of transcatheter edge-to-edge repair in Chinese patients with significant mitral regurgitation: A real-world echocardiographic study.
    Int J Cardiol. 2025;433:133317.
    PubMed     Abstract available
    
    
    
56. MAYNTZ SP, Davidovski FS
    Improving gender-specific management of aortic stenosis with IMPULSE registry data.
    Int J Cardiol. 2025;433:133293.
    PubMed    
    
    
    
57. SITGES M
    Improving our management of tricuspid regurgitation: present and future opportunities.
    Int J Cardiol. 2025 Apr 18:133288. doi: 10.1016/j.ijcard.2025.133288.
    PubMed    
    
    
    
58. MCDONOUGH RV
    Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).
    Int J Cardiol. 2025;432:133260.
    PubMed    
    
    
    
59. JACQUEMYN X, Sa MP, Marin-Cuartas M, Bax JJ, et al
    Early aortic valve replacement versus conservative management in asymptomatic severe aortic stenosis: Meta-analysis of time-to-event data of randomized controlled trials.
    Int J Cardiol. 2025;432:133269.
    PubMed     Abstract available
    
    
    
60. IFTIKHAR MK, Iftikhar QUA, Baig MMA
    Mitral valve reoperation: Refining risk stratification for better outcomes.
    Int J Cardiol. 2025;431:133239.
    PubMed    
    
    
    
61. JAVED MN, Ahmed U, Eman NU
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective.
    Int J Cardiol. 2025;431:133238.
    PubMed    
    
    
    March 2025
62. BLEIZIFFER S, Messika-Zeitoun D, Steeds R, Appleby C, et al
    Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry.
    Int J Cardiol. 2025 Mar 30:133223. doi: 10.1016/j.ijcard.2025.133223.
    PubMed     Abstract available
    
    
    
63. LUO D, Bjornson E, Wang X, Zhang B, et al
    Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.
    Int J Cardiol. 2025 Mar 27:133218. doi: 10.1016/j.ijcard.2025.133218.
    PubMed     Abstract available
    
    
    
64. TRUONG S, Petersen J, Havers-Borgersen E, Schops LB, et al
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Mar 18:133175. doi: 10.1016/j.ijcard.2025.133175.
    PubMed     Abstract available
    
    
    
65. CAI Y, Ou M, Li Y, Zhang X, et al
    Parameters of speckle tracking echocardiography in right atrial fibrosis of patients with rheumatic mitral stenosis: Focusing on right atrial stiffness.
    Int J Cardiol. 2025;429:133170.
    PubMed     Abstract available
    
    
    
66. LAI Q, Wei Z, Zhang X, Li Q, et al
    The passability of delivery catheter system during self-expanding transcatheter aortic valve replacement: A CT-based prediction model.
    Int J Cardiol. 2025 Mar 16:133168. doi: 10.1016/j.ijcard.2025.133168.
    PubMed     Abstract available
    
    
    
67. GODINO C, Nemola G, Sisinni A, Margonato D, et al
    Therapeutical approach of tricuspid regurgitation and right heart failure.
    Int J Cardiol. 2025;429:133163.
    PubMed     Abstract available
    
    
    
68. SONAGLIONI A, Nicolosi GL, Lombardo M
    Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
    Int J Cardiol. 2025;429:133141.
    PubMed    
    
    
    
69. AHMED A, Safiriyu I, Kaddoura R, Mohyeldin M, et al
    Outcomes of transcatheter aortic valve implantation in Africa: A systematic review and meta-analysis.
    Int J Cardiol. 2025 Mar 10:133139. doi: 10.1016/j.ijcard.2025.133139.
    PubMed     Abstract available
    
    
    
70. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
    Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
    PubMed     Abstract available
    
    
    
71. TAKAHARI K, Utsunomiya H, Tohgi K, Hamada A, et al
    Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and adverse outcomes in aortic stenosis with preserved left ventricular ejection fraction.
    Int J Cardiol. 2025 Mar 2:133106. doi: 10.1016/j.ijcard.2025.133106.
    PubMed     Abstract available
    
    
    
72. FERRI LA, Ancona MB, Papageorgiou C, Vella C, et al
    Computed tomography derived predictors of left ventricular obstruction after TAVR.
    Int J Cardiol. 2025;422:132956.
    PubMed     Abstract available
    
    
    
73. KHAN S, Demir O, Mehmood M, Nabi I, et al
    An automated method of streamlining waiting list by clinical risk fast-tracking for patients awaiting TAVR: SWIFT TAVR algorithm.
    Int J Cardiol. 2025;422:132952.
    PubMed     Abstract available
    
    
    
74. SCHOONVELDE SAC, Alexandridis GM, Price LB, Schinkel AFL, et al
    Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
    Int J Cardiol. 2025;422:132951.
    PubMed     Abstract available
    
    
    February 2025
75. AKITA K, Suwa K, Ohno K, Weiner SD, et al
    Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2025;421:132911.
    PubMed     Abstract available
    
    
    
76. GULER A, Erata YE, Demirtola AI, Turkmen I, et al
    The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;421:132913.
    PubMed     Abstract available
    
    
    
77. ZENG X, Wu H, Wang R, Huang P, et al
    Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort study.
    Int J Cardiol. 2025;421:132864.
    PubMed     Abstract available
    
    
    
78. ABBAS MT, Farina JM, Awad K, Badr A, et al
    The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration.
    Int J Cardiol. 2025;425:133067.
    PubMed     Abstract available
    
    
    
79. KOLIASTASIS L, Kim WK
    Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
    Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063.
    PubMed    
    
    
    January 2025
80. ALNABTI A, Abujalala S, Al-Hijji M, Othman K, et al
    Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) -first report 24/7/2024.
    Int J Cardiol. 2025 Jan 29:133029. doi: 10.1016/j.ijcard.2025.133029.
    PubMed     Abstract available
    
    
    
81. TUSA M, Amicone S
    Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.
    Int J Cardiol. 2025 Jan 25:133007. doi: 10.1016/j.ijcard.2025.133007.
    PubMed    
    
    
    
82. LU T, Zhu C, Cui H, Meng Y, et al
    Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy.
    Int J Cardiol. 2025;419:132705.
    PubMed     Abstract available
    
    
    
83. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
    Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
    Int J Cardiol. 2025;419:132694.
    PubMed     Abstract available
    
    
    
84. ZHANG L, Ding F, Ren Z, Cheng W, et al
    Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
    Int J Cardiol. 2025;419:132627.
    PubMed     Abstract available
    
    
    
85. KIM M, Seo J, Kim IS, Cho S, et al
    Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis.
    Int J Cardiol. 2025 Jan 11:132980. doi: 10.1016/j.ijcard.2025.132980.
    PubMed     Abstract available
    
    
    
86. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
    Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
    Int J Cardiol. 2025;422:132958.
    PubMed     Abstract available
    
    
    December 2024
87. GAMARRA-VALVERDE NN, Masket D, Henry ML, Mares AC, et al
    Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions.
    Int J Cardiol. 2024 Dec 28:132946. doi: 10.1016/j.ijcard.2024.132946.
    PubMed     Abstract available
    
    
    
88. ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
    Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
    Int J Cardiol. 2024;421:132910.
    PubMed     Abstract available
    
    
    
89. MUSHTAQ S, Chiesa M, Novelli V, Sommariva E, et al
    Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132554.
    PubMed     Abstract available
    
    
    
90. HAGEGE A, Puscas T, El Hachmi M, Parodi A, et al
    The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132542.
    PubMed     Abstract available
    
    
    
91. CORCIONE N, Ferraro P, Finizio F, Cimmino M, et al
    Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.
    Int J Cardiol. 2024;421:132874.
    PubMed     Abstract available
    
    
    
92. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    PubMed     Abstract available
    
    
    
93. ECHARTE-MORALES J, Scotti A, Bonnet G, Torrado J, et al
    Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry.
    Int J Cardiol. 2024;421:132889.
    PubMed     Abstract available
    
    
    
94. SAIJO Y, Okushi Y, Gillinov AM, Pettersson GB, et al
    Sex-related differences in outcomes and prognosis of severe calcific mitral stenosis due to mitral annular calcification: A propensity-score matched cohort study.
    Int J Cardiol. 2024;421:132893.
    PubMed     Abstract available
    
    
    
95. KIM WK, Bleiziffer S
    Are there sex-specific disparities in transcatheter aortic valve implantation?
    Int J Cardiol. 2024;421:132882.
    PubMed    
    
    
    
96. PANG S, Wu J, Ke Y, Wang Q, et al
    Letter to the Editor: Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2024;421:132883.
    PubMed    
    
    
    
97. YAN T, Weng F, Guo C
    miR-124-3p may exert its effects in hypertrophic cardiomyopathy by inhibiting cardiomyocyte apoptosis.
    Int J Cardiol. 2024;416:132470.
    PubMed    
    
    
    November 2024
98. FEZZI S, Pesarini G, Flaim M, Ding D, et al
    Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
    Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
    PubMed     Abstract available
    
    
    
99. HAFIANE A, Pisaturo A, Favari E, Bortnick AE, et al
    Atherosclerosis, calcific aortic valve disease and mitral annular calcification: Same or different?
    Int J Cardiol. 2024 Nov 16:132741. doi: 10.1016/j.ijcard.2024.132741.
    PubMed     Abstract available
    
    
    
100. BERGHMANS S, Eyskens B, Rega F, Moons P, et al
     A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs.
     Int J Cardiol. 2024;415:132476.
     PubMed     Abstract available
     
     
     
101. SANNA GD, Finocchiaro G
     Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
     Int J Cardiol. 2024;415:132373.
     PubMed    
     
     
     
102. BONAVENTURA J, Maron BJ
     Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
     Int J Cardiol. 2024;415:132366.
     PubMed    
     
     
     
103. PEREIRA AR, Al Jaff AAM, Cabezas JM, de Weger A, et al
     Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach.
     Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712.
     PubMed     Abstract available
     
     
     
104. ABRAHAM B, Sous M, Kaldas S, Nakhla M, et al
     Transcaval access for transcatheter aortic valve implantation: A meta-analysis and systematic review.
     Int J Cardiol. 2024 Nov 11:132720. doi: 10.1016/j.ijcard.2024.132720.
     PubMed     Abstract available
     
     
     
105. LIN S, Zhang Y, Wang S, Ding X, et al
     Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Nov 10:132697. doi: 10.1016/j.ijcard.2024.132697.
     PubMed     Abstract available
     
     
     
106. EL MATHARI S, Hopman LHGA, Bouchnaf C, Heidendael JF, et al
     Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification.
     Int J Cardiol. 2024;414:132443.
     PubMed     Abstract available
     
     
     
107. FERNANDEZ A, Niel N, Parma G, Loza G, et al
     Warfarin use is associated with higher aortic bioprosthetic 18F-fluoride PET uptake.
     Int J Cardiol. 2024;414:132394.
     PubMed     Abstract available
     
     
     October 2024
108. YANG Y, Ye Y
     Women: More susceptible to develop unfavorable in-hospital outcomes after transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Oct 22:132678. doi: 10.1016/j.ijcard.2024.132678.
     PubMed    
     
     
     
109. ALPERI A, Avanzas P
     TAVR in tapered raphe-type stenotic bicuspid aortic valves: excellent results in challenging anatomies.
     Int J Cardiol. 2024 Oct 19:132656. doi: 10.1016/j.ijcard.2024.132656.
     PubMed    
     
     
     
110. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
     External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
     Int J Cardiol. 2024 Oct 19:132653. doi: 10.1016/j.ijcard.2024.132653.
     PubMed     Abstract available
     
     
     
111. FIGLIOZZI S, Masci PG, Monti L, Stankowski K, et al
     Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2024;413:132390.
     PubMed     Abstract available
     
     
     
112. KUMAR M, Hu JR, Ali S, Khlidj Y, et al
     Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study.
     Int J Cardiol. 2024;418:132619.
     PubMed     Abstract available
     
     
     
113. TRUONG S, Petersen J, Schmiegelow MDS, Due H, et al
     Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study.
     Int J Cardiol. 2024;418:132608.
     PubMed     Abstract available
     
     
     September 2024
114. SAITO T, Tsuruta H, Iwata J, Kajino A, et al
     Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.
     Int J Cardiol. 2024 Sep 24:132595. doi: 10.1016/j.ijcard.2024.132595.
     PubMed     Abstract available
     
     
     
115. BUONO A, De Biase C, Fabris T, Bellamoli M, et al
     CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry.
     Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569.
     PubMed     Abstract available
     
     
     
116. HARIKRISHNAN S, Koshy L, Ganapathi S, Jeemon P, et al
     Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;411:132273.
     PubMed     Abstract available
     
     
     
117. BANSAL S, Gupta A
     TAVR outcomes in females - What is changing!
     Int J Cardiol. 2024;411:132247.
     PubMed    
     
     
     
118. ABU-MUCH A, Grines CL, Chen S, Batchelor WB, et al
     Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
     Int J Cardiol. 2024;417:132555.
     PubMed     Abstract available
     
     
     
119. PISKLOVA M, Osmak G
     Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
     Int J Cardiol. 2024;410:132220.
     PubMed     Abstract available
     
     
     
120. GOMEZ-HERRERO J, Fernandez-Cordon C, Gonzalez JC, Garcia-Gomez M, et al
     TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes.
     Int J Cardiol. 2024;410:132179.
     PubMed     Abstract available
     
     
     August 2024
121. MARGONATO D
     The therapeutical role of balloon aortic valvuloplasty: Back to the origin?
     Int J Cardiol. 2024 Aug 28:132493. doi: 10.1016/j.ijcard.2024.132493.
     PubMed    
     
     
     
122. BONFIOLI GB, Pagnesi M
     Pulmonary vein flow pattern: A marker of successful repair in primary mitral regurgitation?
     Int J Cardiol. 2024 Aug 28:132498. doi: 10.1016/j.ijcard.2024.132498.
     PubMed    
     
     
     
123. LAI KY, Lee CY, Chang YC, Liu K, et al
     Prognostic value of fully-automated left atrial strain in patients with asymptomatic chronic severe aortic regurgitation.
     Int J Cardiol. 2024 Aug 27:132487. doi: 10.1016/j.ijcard.2024.132487.
     PubMed     Abstract available
     
     
     
124. LIU T, Yang X, Jia R, Han J, et al
     Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
     Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
     PubMed     Abstract available
     
     
     
125. HUANG Z, Lin K, Huang J, Chen Y, et al
     Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2024;409:132213.
     PubMed     Abstract available
     
     
     
126. FAN J, Li Z, Lin D, Miao J, et al
     Long-term outcomes in patients with bicuspid valve stenosis and aortic dilation undergoing transcatheter valve implantation.
     Int J Cardiol. 2024;409:132201.
     PubMed     Abstract available
     
     
     
127. FAGGI A, Denti P
     Contemporary TAVI counterindications and space for staged procedures.
     Int J Cardiol. 2024;409:132172.
     PubMed    
     
     
     
128. NASIR MM, Amir S, Shahid A, Rehman WU, et al
     Valve-in-valve transcatheter mitral valve replacement versus redo-surgical mitral valve replacement for degenerated bioprosthetic mitral valves: A systematic review and meta-analysis.
     Int J Cardiol. 2024;415:132448.
     PubMed     Abstract available
     
     
     
129. AMSALEM I, Carasso S
     Increased utilization of mitral transcatheter edge-to-edge repair in degenerative mitral regurgitation: The essential need for better prognostic and procedural success tools.
     Int J Cardiol. 2024 Aug 14:132457. doi: 10.1016/j.ijcard.2024.132457.
     PubMed    
     
     
     
130. GE Z, Ge Z, Hu C, Wang Y, et al
     Characteristic of myocardial work in mitral valve prolapse with versus without mitral annular disjunction: A propensity-matched study.
     Int J Cardiol. 2024 Aug 6:132434. doi: 10.1016/j.ijcard.2024.132434.
     PubMed     Abstract available
     
     
     
131. YEDIDYA I, Stassen J, Butcher S, van Wijngaarden AL, et al
     The prognostic value of changes in pulmonary vein flow patterns after surgical repair for primary mitral regurgitation.
     Int J Cardiol. 2024;414:132414.
     PubMed     Abstract available
     
     
     
132. YAGI N, Hasegawa H, Kuwajima K, Ogawa M, et al
     Indexed aortic valve area using multimodality imaging for assessing the severity of bicuspid aortic stenosis.
     Int J Cardiol. 2024;414:132416.
     PubMed     Abstract available
     
     
     
133. SPRINGHETTI P, Tomaselli M, Clavel MA
     Measuring the aortic valvular area: Key challenges in aortic stenosis assessment.
     Int J Cardiol. 2024;414:132410.
     PubMed    
     
     
     
134. LORCA R, Salgado M, Alvarez-Velasco R, Reguro JR, et al
     Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
     Int J Cardiol. 2024;408:132117.
     PubMed     Abstract available
     
     
     
135. TONDI L, Pica S, Crimi G, Disabato G, et al
     "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
     Int J Cardiol. 2024;408:132135.
     PubMed     Abstract available
     
     
     
136. BESOLA L, Falcetta G, Ceravolo G, Fiocco A, et al
     New echocardiographic screening tool for left ventricular tract obstruction risk assessment in TMVR.
     Int J Cardiol. 2024;408:132112.
     PubMed     Abstract available
     
     
     July 2024
137. HUSSAIN B, Tarabanis C, Aslam MMS, Dhulipala V, et al
     Inpatient outcomes of mechanical circulatory support devices and heart transplantation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;413:132396.
     PubMed     Abstract available
     
     
     
138. RAHOUMA M, Khairallah S, Lau C, Al Zghari T, et al
     The impact of comorbidities on outcomes of concomitant mitral valve intervention with ascending aortic surgery.
     Int J Cardiol. 2024;413:132398.
     PubMed     Abstract available
     
     
     
139. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
     Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
     Int J Cardiol. 2024;413:132399.
     PubMed     Abstract available
     
     
     
140. TOMSIC A, Holubec T, Sandoval E, Pham T, et al
     Mitral valve repair with resection and non-resection techniques in Barlow's disease: A multi-center study.
     Int J Cardiol. 2024 Jul 22:132387. doi: 10.1016/j.ijcard.2024.132387.
     PubMed     Abstract available
     
     
     
141. DE FELICE F, Musto C, Paolucci L
     TAVR in bicuspid aortic valve and ascending aorta dilatation: sitting on a fence or jumping on the bandwagon.
     Int J Cardiol. 2024 Jul 19:132372. doi: 10.1016/j.ijcard.2024.132372.
     PubMed    
     
     
     
142. AMADOR AF
     Edmonton frail scale in TAVI patients: A new tool for frailty assessment and outcomes prediction.
     Int J Cardiol. 2024;407:132024.
     PubMed    
     
     
     
143. DAYAN V, Fernandez A, Loza G, Parma G, et al
     Early anticoagulation after aortic valve replacement with porcine bioprosthesis randomized control trial(ANTIPRO). 3?years follow-up.
     Int J Cardiol. 2024 Jul 12:132361. doi: 10.1016/j.ijcard.2024.132361.
     PubMed     Abstract available
     
     
     
144. ALBANI S, Merlo M
     Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
     Int J Cardiol. 2024;413:132357.
     PubMed    
     
     
     
145. LOFFI M, Adamo M, Rubbio AP, Pezzola E, et al
     Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jul 8:132317. doi: 10.1016/j.ijcard.2024.132317.
     PubMed     Abstract available
     
     
     
146. FUJIMOTO T, Zen K, Kataoka E, Kitada T, et al
     Balloon aortic valvuloplasty bridge to transcatheter aortic valve replacement is associated with worse in-hospital mortality.
     Int J Cardiol. 2024 Jul 6:132348. doi: 10.1016/j.ijcard.2024.132348.
     PubMed     Abstract available
     
     
     
147. OMAR P, Giovanni B, Williams J, Thomas F, et al
     Quantification of anatomical aortic valve area by multi-detector computed tomography: A pilot 3D-morphological modeling of the stenotic aortic valve.
     Int J Cardiol. 2024 Jul 6:132322. doi: 10.1016/j.ijcard.2024.132322.
     PubMed     Abstract available
     
     
     
148. HEEGER CH, Alagjozovski H
     Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024;412:132299.
     PubMed    
     
     
     
149. BONANNI M, Russo G, De Siati M, Tomao F, et al
     Holographic mixed reality for planning transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Jul 2:132330. doi: 10.1016/j.ijcard.2024.132330.
     PubMed     Abstract available
     
     
     
150. TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
     Ascending aortic dilatation in TAVI: Actor or bystander?
     Int J Cardiol. 2024;406:132089.
     PubMed    
     
     
     June 2024
151. RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
     Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
     Int J Cardiol. 2024;405:131934.
     PubMed     Abstract available
     
     
     
152. LV J, Wu Y, Xu H
     Transcatheter mitral valve intervention in patients with cancer: More efforts are needed.
     Int J Cardiol. 2024 Jun 15:132271. doi: 10.1016/j.ijcard.2024.132271.
     PubMed    
     
     
     
153. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
     Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
     PubMed     Abstract available
     
     
     
154. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Valve-in-valve after transcatheter aortic valve embolization: Do we need to align the commissures?
     Int J Cardiol. 2024 Jun 11:132255. doi: 10.1016/j.ijcard.2024.132255.
     PubMed    
     
     
     
155. D'AMARIO D, Laborante R, Mennuni M, Adamo M, et al
     Efficacy and safety of trans-catheter repair devices for mitral regurgitation: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132245. doi: 10.1016/j.ijcard.2024.132245.
     PubMed     Abstract available
     
     
     
156. AYYAD M, Jabri A, Khalefa BB, Al-Abdouh A, et al
     Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132243. doi: 10.1016/j.ijcard.2024.132243.
     PubMed     Abstract available
     
     
     
157. KIRCHNER J, Gercek M, Gesch J, Omran H, et al
     Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair.
     Int J Cardiol. 2024 Jun 5:132233. doi: 10.1016/j.ijcard.2024.132233.
     PubMed     Abstract available
     
     
     
158. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
     Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
     PubMed     Abstract available
     
     
     
159. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     Response to: Regard to assessing agreement between two raters with kappa statistics.
     Int J Cardiol. 2024;404:131978.
     PubMed    
     
     
     
160. GESKE JB, Schaff HV
     Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
     Int J Cardiol. 2024;404:131961.
     PubMed    
     
     
     
161. ANG SP, Chia JE
     Reevaluating female survival benefit in TAVR: A closer look in the current era.
     Int J Cardiol. 2024;404:131935.
     PubMed    
     
     
     May 2024
162. SHI W, Feng D, Hu X, Wang C, et al
     Prediction of hypoattenuating leaflet thickening in patients underwent transcatheter aortic valves replacement based on clinical factors and 4D-computed tomography morphological characteristics: A retrospective cross-sectional study.
     Int J Cardiol. 2024 May 28:132219. doi: 10.1016/j.ijcard.2024.132219.
     PubMed     Abstract available
     
     
     
163. AURIGEMMA C, Busco M, Bianchini F, Bianchini E, et al
     Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
     Int J Cardiol. 2024 May 28:132218. doi: 10.1016/j.ijcard.2024.132218.
     PubMed     Abstract available
     
     
     
164. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
     Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
     Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
     PubMed     Abstract available
     
     
     
165. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
     Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
     PubMed     Abstract available
     
     
     
166. MARTIN M, Rozado J
     Imaging in severe aortic stenosis: Looking at the future.
     Int J Cardiol. 2024 May 16:132183. doi: 10.1016/j.ijcard.2024.132183.
     PubMed    
     
     
     
167. SEE C, Kim Y, Park J, Wang Y, et al
     High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
     Int J Cardiol. 2024 May 14:132174. doi: 10.1016/j.ijcard.2024.132174.
     PubMed     Abstract available
     
     
     
168. MONDA E, Boccia A, Altobelli I, Mauriello A, et al
     Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
     Int J Cardiol. 2024;408:132067.
     PubMed     Abstract available
     
     
     
169. VOGES I, Hansen JH
     Critical aortic stenosis - The long-term burden.
     Int J Cardiol. 2024;408:132134.
     PubMed    
     
     
     
170. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
     Int J Cardiol. 2024;402:131883.
     PubMed    
     
     
     
171. VESELKA J
     Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
     Int J Cardiol. 2024;402:131842.
     PubMed    
     
     
     
172. GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
     Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
     PubMed     Abstract available
     
     
     April 2024
173. QIU Y, Li M, Song X, Li Z, et al
     Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
     Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
     PubMed     Abstract available
     
     
     
174. LEE CY, Tsai CM, Chiang KC, Huang CC, et al
     Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
     Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
     PubMed     Abstract available
     
     
     
175. CHEN B, Zhang Q
     The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
     PubMed    
     
     
     
176. MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
     Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
     Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
     PubMed     Abstract available
     
     
     
177. GUO Y, Li H, Huang B, Hou L, et al
     LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
     Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
     PubMed    
     
     
     
178. GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
     Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
     Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
     PubMed     Abstract available
     
     
     
179. DAHME T
     Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
     Int J Cardiol. 2024;406:132066.
     PubMed    
     
     
     
180. SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
     Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
     Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
     PubMed    
     
     
     
181. PRAKASH SK
     Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
     Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
     PubMed    
     
     
     
182. CHENG Y, Zhang Q
     Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
     PubMed    
     
     
     
183. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
     Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;400:131790.
     PubMed     Abstract available
     
     
     
184. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
     Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
     Int J Cardiol. 2024;400:131768.
     PubMed     Abstract available
     
     
     March 2024
185. SANG SLW, Weissman C, Parker J, Timek T, et al
     Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
     Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
     PubMed     Abstract available
     
     
     
186. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
     Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
     Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
     PubMed     Abstract available
     
     
     
187. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
     Patterns of aortic valve replacement in Europe and adoption by sex.
     Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
     PubMed     Abstract available
     
     
     
188. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
     Management of prosthetic valve thrombosis with unfractionated heparin.
     Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
     PubMed     Abstract available
     
     
     
189. BICHUETTE LD, Lottenberg MP, Caramelli B
     Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
     Int J Cardiol. 2024;399:131683.
     PubMed    
     
     
     
190. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
     Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;399:131661.
     PubMed     Abstract available
     
     
     
191. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
     Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
     Int J Cardiol. 2024;399:131662.
     PubMed     Abstract available
     
     
     
192. FENG D, Zhao J, Niu G, Zhang Y, et al
     Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
     Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
     PubMed     Abstract available
     
     
     
193. BONELLO B, Issitt R, Hughes M, Carr M, et al
     Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
     Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
     PubMed     Abstract available
     
     
     
194. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
     Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
     Int J Cardiol. 2024;398:131601.
     PubMed     Abstract available
     
     
     
195. LIU Z, Wei P, Jiang H, Zhang F, et al
     Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
     Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
     PubMed    
     
     
     February 2024
196. BOURG C, Lee KC, Donal E
     Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
     Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
     PubMed    
     
     
     
197. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
     Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
     Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
     PubMed     Abstract available
     
     
     
198. AKHTAR KH, Pahuja M, Baber U
     Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
     Int J Cardiol. 2024;397:131619.
     PubMed    
     
     
     
199. DE MARZO V, Zimarino M
     The value of transaxillary access for TAVI.
     Int J Cardiol. 2024;397:131448.
     PubMed    
     
     
     
200. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
     Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
     Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
     PubMed     Abstract available
     
     
     
201. DANDEL M
     It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
     Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
     PubMed    
     
     
     
202. KWAK S, Lee HJ, Lee H, Park JB, et al
     Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;396:131574.
     PubMed     Abstract available
     
     
     January 2024
203. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
     Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
     Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
     PubMed     Abstract available
     
     
     
204. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
     ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
     Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
     PubMed     Abstract available
     
     
     
205. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
     Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
     Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
     PubMed     Abstract available
     
     
     
206. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
     Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
     Int J Cardiol. 2024;395:131572.
     PubMed     Abstract available
     
     
     
207. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
     Int J Cardiol. 2024;395:131416.
     PubMed     Abstract available
     
     
     
208. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
     Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
     Int J Cardiol. 2024;395:131413.
     PubMed    
     
     
     
209. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
     Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
     PubMed     Abstract available
     
     
     
210. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
     Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
     Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
     PubMed     Abstract available
     
     
     
211. LERMAN TT, Levi A, Kornowski R
     Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
     Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
     PubMed    
     
     
     
212. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
     Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
     Int J Cardiol. 2024;394:131353.
     PubMed     Abstract available
     
     
     December 2023
213. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
     Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
     Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
     PubMed     Abstract available
     
     
     
214. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
     Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
     PubMed     Abstract available
     
     
     
215. HIRAM R
     The duration of atrial fibrillation might be associated with right heart disease severity.
     Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
     PubMed    
     
     
     
216. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
     Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
     Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
     PubMed     Abstract available
     
     
     
217. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
     Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
     PubMed     Abstract available
     
     
     
218. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
     Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
     Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
     PubMed     Abstract available
     
     
     
219. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
     Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
     Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
     PubMed     Abstract available
     
     
     
220. BOLETI OD, Roussos S, Norrish G, Field E, et al
     Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
     Int J Cardiol. 2023;393:131405.
     PubMed     Abstract available
     
     
     
221. OZLEK B
     Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
     Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
     PubMed    
     
     
     
222. GOZDEK M, Kowalewski M
     Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
     Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
     PubMed    
     
     
     
223. SEE C, Wang Y, Yang Y, Tirziu D, et al
     Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
     Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
     PubMed     Abstract available
     
     
     
224. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
     Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
     Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
     PubMed     Abstract available
     
     
     
225. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
     Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
     Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
     PubMed     Abstract available
     
     
     November 2023
226. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
     Unmasking tricuspid regurgitation.
     Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
     PubMed    
     
     
     
227. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
     Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
     Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
     PubMed     Abstract available
     
     
     
228. CHAN J, Narayan P, Fudulu DP, Dong T, et al
     Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
     Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
     PubMed     Abstract available
     
     
     
229. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
     The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
     Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
     PubMed     Abstract available
     
     
     
230. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
     About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
     PubMed     Abstract available
     
     
     
231. HU D, Lan T, Chen Y, Chen L, et al
     An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
     Int J Cardiol. 2023;391:131286.
     PubMed     Abstract available
     
     
     
232. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
     Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
     Int J Cardiol. 2023;391:131265.
     PubMed     Abstract available
     
     
     
233. WU Z, Nie C, Zhu C, Meng Y, et al
     Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
     Int J Cardiol. 2023;391:131266.
     PubMed     Abstract available
     
     
     
234. DE SARRO R, Sabatino J
     Left atrial function's evaluation in aortic stenosis: A clinical imperative.
     Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
     PubMed    
     
     
     
235. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
     Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
     PubMed     Abstract available
     
     
     
236. ZHOU N, Liu A, Weng H, Liu W, et al
     Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
     Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
     PubMed     Abstract available
     
     
     
237. DORES H, Toste A, Cardim N
     Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
     Int J Cardiol. 2023;390:131260.
     PubMed     Abstract available
     
     
     
238. SALA A, Alfieri O
     Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
     Int J Cardiol. 2023;390:131146.
     PubMed    
     
     
     
239. NEMES A
     Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
     Int J Cardiol. 2023;390:131170.
     PubMed    
     
     
     October 2023
240. BRANDES A
     Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
     Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
     PubMed    
     
     
     
241. LIU Z, Wei P, Jiang H, Zhang F, et al
     Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
     Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
     PubMed     Abstract available
     
     
     
242. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
     Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
     PubMed     Abstract available
     
     
     
243. HOU Q, Wu W, Fang L, Zhang X, et al
     Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
     Int J Cardiol. 2023;389:131263.
     PubMed     Abstract available
     
     
     
244. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
     Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
     Int J Cardiol. 2023;389:131194.
     PubMed     Abstract available
     
     
     
245. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
     Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
     Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
     PubMed     Abstract available
     
     
     
246. BHOGAL S, Waksman R, Shea C, Zhang C, et al
     Self-expanding and balloon-expandable valves in low risk TAVR patients.
     Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
     PubMed     Abstract available
     
     
     
247. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
     Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
     Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
     PubMed     Abstract available
     
     
     
248. CHEN X
     The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;388:131172.
     PubMed    
     
     
     
249. MARTIN M, Moris C
     Subclinical leaflet thrombosis after TAVI: To be or not to be.
     Int J Cardiol. 2023;388:131140.
     PubMed    
     
     
     September 2023
250. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
     Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
     PubMed     Abstract available
     
     
     
251. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
     Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
     PubMed     Abstract available
     
     
     
252. CHANG WT, Lin CH, Lee WC, Kan WC, et al
     Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
     Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
     PubMed     Abstract available
     
     
     
253. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
     Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2023;387:131099.
     PubMed     Abstract available
     
     
     
254. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
     Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
     Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
     PubMed     Abstract available
     
     
     
255. LEOW R, Kong WKF, Li TY, Poh KK, et al
     Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
     Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
     PubMed     Abstract available
     
     
     
256. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
     Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
     Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
     PubMed     Abstract available
     
     
     
257. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
     Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
     Int J Cardiol. 2023;386:17-23.
     PubMed     Abstract available
     
     
     August 2023
258. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
     Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
     Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
     PubMed     Abstract available
     
     
     
259. LI S, Fang L, Wu W, Zhang Z, et al
     Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
     Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
     PubMed     Abstract available
     
     
     
260. PIERONI M, Ciabatti M, Bolognese L
     Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
     Int J Cardiol. 2023;385:41-42.
     PubMed    
     
     
     
261. NEMES A
     The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
     Int J Cardiol. 2023;385:22.
     PubMed    
     
     
     July 2023
262. SISINNI A, Estevez-Loureiro R
     The K-clip: Time for a new tricuspid valve focal annuloplasty system.
     Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
     PubMed    
     
     
     
263. BARKI M, Ielasi A, Buono A, Maffeo D, et al
     Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
     Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
     PubMed     Abstract available
     
     
     
264. SANCHIS L, Farrero M
     Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
     Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
     PubMed    
     
     
     
265. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
     Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
     Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
     PubMed     Abstract available
     
     
     
266. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
     Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
     PubMed     Abstract available
     
     
     
267. ZHANG X, Jin Q, Pan W, Li W, et al
     First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
     Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
     PubMed     Abstract available
     
     
     
268. CHATTERJEE A, Kazui T, Acharya D
     Growing prevalence of aortic stenosis - Question of age or better recognition?
     Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
     PubMed    
     
     
     
269. XU Z, Dai XF, Lin F, Chen LW, et al
     Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
     Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
     PubMed     Abstract available
     
     
     
270. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
     How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
     Int J Cardiol. 2023;382:64-67.
     PubMed     Abstract available
     
     
     
271. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
     Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
     Int J Cardiol. 2023;382:12-19.
     PubMed     Abstract available
     
     
     June 2023
272. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
     The long-term clinical course of moderate tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
     PubMed     Abstract available
     
     
     
273. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
     Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
     Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
     PubMed     Abstract available
     
     
     
274. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
     2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
     Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
     PubMed     Abstract available
     
     
     
275. LEE M, Shechter A, Han D, Nguyen LC, et al
     Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;381:62-69.
     PubMed     Abstract available
     
     
     
276. BOURG C, Curtis E, Donal E
     Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
     PubMed    
     
     
     
277. RAHIMI M, Kpodonu J
     Myectomy or myomectomy, that is the question.
     Int J Cardiol. 2023;380:28.
     PubMed    
     
     
     
278. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
     Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
     Int J Cardiol. 2023;380:65-71.
     PubMed     Abstract available
     
     
     May 2023
279. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
     Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
     Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
     PubMed     Abstract available
     
     
     
280. ZHOU Y, Lin X, Zhu Q, Li H, et al
     Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
     PubMed     Abstract available
     
     
     
281. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
     Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
     PubMed     Abstract available
     
     
     
282. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
     Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
     PubMed     Abstract available
     
     
     April 2023
283. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
     Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
     Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
     PubMed     Abstract available
     
     
     
284. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
     Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
     Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
     PubMed     Abstract available
     
     
     
285. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
     Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
     Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
     PubMed     Abstract available
     
     
     
286. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
     Factors associated with the progression of aortic valve calcification in older adults.
     Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
     PubMed     Abstract available
     
     
     
287. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
     Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
     Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
     PubMed     Abstract available
     
     
     
288. MERLO M, Folgheraiter A, Sinagra G
     Evolving mortality and clinical scenarios in HCM: Where are we?
     Int J Cardiol. 2023;376:97-99.
     PubMed    
     
     
     March 2023
289. MENG H, Zhao X, Wang JD, Wan LY, et al
     Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
     PubMed     Abstract available
     
     
     
290. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
     Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
     Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
     PubMed     Abstract available
     
     
     
291. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
     The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
     PubMed     Abstract available
     
     
     
292. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
     Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
     Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
     PubMed     Abstract available
     
     
     February 2023
293. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
     Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
     Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
     PubMed     Abstract available
     
     
     
294. MALTES S, Abecasis J, Santos RR, Lopes P, et al
     LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
     Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.